العلاج الجراحي لأورام المعدة الخبيثة

Authors

  • محمود دبرها
  • علي كفا
  • وائل شتور

Abstract

أُجريت الدراسة في مشفى الأسد الجامعي في مدينة اللاذقيّة, وشملت 56 مريضاً تمّ قبولهم وعُولجوا جراحياً من أورام معديّة خبيثة خلال الأعوام من 1997 وحتّى 2009, وكانت نسبة إصابة الذكور إلى الإناث 1:1.55, مع ذروة حدوث في العقد السادس والسابع بنسبة 62.5%, وكانت النّسبة الأعلى لتوضّع الورم في الثّلث السفلي من المعدة بنسبة 62.5 %.

كانت السرطانة الغديّة أكثر الأنماط التشريحيّة المرضيّة شيوعاَ 92.86%, ويشكّل نموذج خلايا الخاتم ذي الفصّ نسبة  23.07%, و أُجري تصنيف Lauren في 8.93% من الحالات.

كان قطع المعدة تحت التّام هو الإجراء الجراحي الأكثر مزاولةً بنسبة 50% من الحالات, مع مفاغرة معديّة صائميّة من النمط أوميغا براون أمام القولون في ثلثي الحالات.

أُجري التجريف D1 في 77.78% من الحالات, في حين أُجري التجريفD2  في 22.22% من الحالات.

تمّ استئصال الطحال في 20.37% من الحالات, وتمّ استئصال المرارة في 3.7% من الحالات.

This study was carried out at AL-ASSAD University Hospital in Lattakia during
1997-2009, and included 56 patients who were treated of gastric cancer. Male: female ratio was 1.55:1, with the peak incidence being in the 6th and 7th decades (62.5%); the highest incidence was in the lower third of the stomach in 62.5% of cases. Adenocarcinoma was the most common pathological form 92.86%; signet ring cells formed 23.07%; lauren classification was performed in 8.93% of cases. The most common operation was subtotal gastrectomy, with Omega-Brawn anastomosis, interiorly of the colon in the two thirds of cases. D1 dissection was performed in 77.78% of cases, compared with D2 dissection which was performed in 22.22 % of cases. Splenectomy was performed in20.37 % of cases, and cholecystectomy in 3.7% of cases.

Downloads

Published

2019-01-17

How to Cite

1.
دبرها م, كفا ع, شتور و. العلاج الجراحي لأورام المعدة الخبيثة. Tuj-hlth [Internet]. 2019Jan.17 [cited 2024Apr.25];31(4). Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/6651

Issue

Vol. 31 No. 4 (2009): العلوم الصحية

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Most read articles by the same author(s)

1 2 > >>